GC Therapeutics

Empowering SuperCells. Restoring Hope.

Cambridge, United States · Founded 2019 · $65.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Website
gc-tx.com
Total Funding
$65.0M
Last Round
$65.0M Series ASep 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

GC Therapeutics (GCTx) is a Cambridge, MA-based biopharmaceutical company using synthetic biology and its proprietary TFome iPSC programming platform to convert patient-derived stem cells into therapeutic cell types with best-in-class efficiency. Founded by scientists from George Church's lab at Harvard, GCTx is developing allogeneic cell therapies for gastrointestinal, neurological, and immunological diseases.

Summary

GC Therapeutics is a Healthcare company based in Cambridge, United States, founded in 2019. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in Sep 2024. Investors include Cormorant Asset Management and Andreessen Horowitz.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2024
$65.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GC Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/gc-therapeutics"><img src="https://indexed.vc/api/badge/company/gc-therapeutics" alt="GC Therapeutics on Indexed.vc" width="260" height="76" /></a>